Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?

Hepatology. 2018 Aug;68(2):786. doi: 10.1002/hep.29862.

Authors

Xiu-Ping Zhang¹, Kang Wang¹, Wei-Xing Guo¹, Zhen-Hua Chen¹, Shu-Qun Cheng¹

Affiliation

¹ Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital Second, Military Medical University, Shanghai, China.

PMID: 29500904
DOI: 10.1002/hep.29862

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adult
Carcinoma, Hepatocellular*
Humans
Liver Neoplasms*
Niacinamide
Phenylurea Compounds
Sorafenib

Substances

Phenylurea Compounds
Niacinamide
Sorafenib